What to watch at #ESMO26 in melanoma and skin cancers 👇 INTerpath-001 (LBA1), STARBOARD, HBI-8000-303, TIL, NADINA, C-POST, ADMEC-O, MATISSE 2. Plus ADCs after anti-PD-1, HER3-DXd (2073RO) and enfortumab vedotin + pembrolizumab (2074RO). @myESMO @OncoAlert @ImiItaliano https://t.co/Sy8j5ghW92